CD4 and myeloid sarcoma: Analogously to what is described for T1DM, activated CD4+ T cells from MS patients display an up-regulation of aerobic glycolysis and down-regulation of OXPHOS (232), as well as altered mitochondrial structure, mitochondrial DNA (mtDNA) levels and membrane potential (233).